Instrument Assisted Soft Tissue Mobilization in Heel pain

Effect of Ergon® Instrument-Assisted Soft Tissue Mobilization and dynamic stretching on superficial myofascial lines in obese adults with Achilles tendinopathy: A Randomized Controlled Trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063540

Enrollment

Registered

2024-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M629- Disorder of muscle, unspecified

Interventions

Intervention1: ERGON IASTM( Instrument Assisted Soft Tissue Mobilization): Participants will receive Ergon® IASTM sessions twice a week for eight weeks. Each session will last 30 minutes. ERGON Uses v

Eligibility

Inclusion criteria

Inclusion criteria: BMI in the obese range (=30 kg/m²). -Diagnosis of retro calcaneal pain. -Participants willing to give their inform consent and adherence to study duration of 8 weeks

Exclusion criteria

Exclusion criteria: Recent foot or ankle surgery. - Recent fractures - Systemic conditions affecting lower extremity function like SLE, RA, and disorders like GOUT or any other form of arthritis . Allergy to materials used in IASTM.

Design outcomes

Primary

Measure	Time frame
1. NPRS score for pain intensity. 2. Foot and Ankle Disability Index (FADI) for functional disability. 3. Short Form Health Survey (SF-36) for quality of life. 4. Ankle ROM pre and post Assessment using standard goniometer. Timepoint: Basline, 4 weeks, 8 weeks, Follow up after 4 months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Aksh Chahal

Galgotias University

sidufatima@gmail.com6006204628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026